What is F4 (Fibrosis stage 4) liver fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

F4 fibrosis represents the most advanced stage of liver fibrosis, also known as cirrhosis, characterized by extensive scarring throughout the liver, replacing healthy liver tissue with fibrous tissue, as reported in a recent systematic review and meta-analysis published in The Lancet Gastroenterology and Hepatology 1.

Diagnosis and Classification

The diagnosis of F4 fibrosis can be made through liver biopsy, imaging studies like FibroScan, or blood tests that measure markers of liver damage, such as the aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis-4 (FIB-4) scores, with the latter being generally available, simple, and inexpensive, but may lack sensitivity in certain populations 1. The METAVIR scoring system classifies liver fibrosis from F0 (no fibrosis) to F4 (cirrhosis), with F4 indicating the most severe stage.

Causes and Complications

Common causes of F4 fibrosis include chronic hepatitis B or C infection, alcohol abuse, non-alcoholic fatty liver disease, and autoimmune liver diseases. The scarring of F4 fibrosis is generally irreversible, and treatment focuses on addressing the underlying cause to prevent further damage, managing complications like portal hypertension and ascites, and monitoring for liver cancer, which occurs more frequently in cirrhotic patients, as highlighted in a study published in the Journal of Hepatology 1.

Management and Prognosis

In some cases, liver transplantation may be necessary when liver function becomes severely compromised. The choice of treatment regimen and post-treatment prognosis and surveillance for hepatocellular carcinoma (HCC) depend on the stage of fibrosis, emphasizing the importance of accurate diagnosis and staging of liver fibrosis, as noted in a recent study published in The Lancet Gastroenterology and Hepatology 1. The management of F4 fibrosis should prioritize the prevention of further liver damage, management of complications, and regular monitoring for liver cancer, with liver transplantation considered in cases of severe liver dysfunction, as supported by the most recent evidence 1.

From the Research

Definition of F4 Fibrosis

F4 fibrosis refers to the most advanced stage of liver fibrosis, which is characterized by the formation of regenerative nodules surrounded by fibrotic tissue, indicating the presence of cirrhosis 2, 3, 4, 5, 6.

Characteristics of F4 Fibrosis

Patients with F4 fibrosis have a higher risk of developing liver-related complications, such as variceal bleeding, ascites, and hepatic encephalopathy, compared to those with F3 fibrosis 2. F4 fibrosis is also associated with a higher risk of hepatocellular carcinoma and liver-related death 3, 4.

Diagnosis and Treatment of F4 Fibrosis

The diagnosis of F4 fibrosis is typically made through liver biopsy, although non-invasive methods such as liver stiffness measurement are also being used 4. Treatment of F4 fibrosis usually involves antiviral therapy, such as entecavir or sofosbuvir, which can help to improve liver histology and reduce the risk of liver-related complications 5, 6.

Key Features of F4 Fibrosis

  • Advanced stage of liver fibrosis
  • Characterized by the formation of regenerative nodules surrounded by fibrotic tissue
  • Higher risk of liver-related complications, such as variceal bleeding, ascites, and hepatic encephalopathy
  • Associated with a higher risk of hepatocellular carcinoma and liver-related death
  • Diagnosis typically made through liver biopsy
  • Treatment usually involves antiviral therapy, such as entecavir or sofosbuvir

Comparison with F3 Fibrosis

  • Patients with F4 fibrosis have a higher risk of developing liver-related complications compared to those with F3 fibrosis 2
  • F4 fibrosis is associated with a higher risk of hepatocellular carcinoma and liver-related death compared to F3 fibrosis 3, 4
  • Treatment outcomes may differ between F3 and F4 fibrosis, with F4 fibrosis requiring more aggressive treatment 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Role of assessing liver fibrosis in management of chronic hepatitis C virus infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016

Research

Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.

Liver international : official journal of the International Association for the Study of the Liver, 2013

Research

Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2011

Research

Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.